In vitro chondrogenic phenotype differentiation of bone marrow-derived mesenchymal stem cells

Zhang Yufu , Wang Changyong , Liao Wen , Li Zhanghua , Guo Ximin , Zhao Qiang , Duan Cuimi , Xia Renyun

Current Medical Science ›› 2004, Vol. 24 ›› Issue (23) : 275 -278.

PDF
Current Medical Science ›› 2004, Vol. 24 ›› Issue (23) : 275 -278. DOI: 10.1007/BF02832011
Article

In vitro chondrogenic phenotype differentiation of bone marrow-derived mesenchymal stem cells

Author information +
History +
PDF

Abstract

In order to study the chondrogenic phenotype differentiation of adult sheep bone marrow-derived mesenchymal stem cells (MSCs) in a defined medium as potential seed cells for cartilage tissue engineering, MSCs were isolated by density centrifugation with Percoll solution from bone marrow aspirated from sheep iliac crest. The third passage of MSCs were induced with H-DMEM containing TGF-β3. IGF I. Dexamethasone and VitC. The shape and ultrastructure of cells were observed, toluidine blue stain for GAG and immunohistochemistry for type II collagen were applied for chondrogenic phenotype identification. After 14 days of induction, MSCs changed from a spindle-like appearance to a polynal shape, a large amount of endoplasmic reticulum. Golgi complex and mitochondria were observed, and the differentiation of MSCs chondrogenic phenotype was verified by positive staining of toluidine blue and immunohistochemistry. MSCs derived from bone marrow can differentiate to chondrogenic phenotype when inducedin vitro and can be used as optimal seed cells for cartilage tissue engineering.

Keywords

mesenchymal stem cells / chondrocyte / tissue engineering

Cite this article

Download citation ▾
Zhang Yufu, Wang Changyong, Liao Wen, Li Zhanghua, Guo Ximin, Zhao Qiang, Duan Cuimi, Xia Renyun. In vitro chondrogenic phenotype differentiation of bone marrow-derived mesenchymal stem cells. Current Medical Science, 2004, 24(23): 275-278 DOI:10.1007/BF02832011

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

PittengerM F, MackayA M, BeckS C, et al. . Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284(5411): 143-143

[2]

PetersonL, MinasT, BrittbergM, et al. . Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J Bone Joint Surg Am, 2003, 85-A(Suppl 2): 17-17

[3]

ImG I, KimD Y, ShinJ H, et al. . Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J Bone Joint Surg Br, 2001, 83(2): 289-289

[4]

KocO N, LazarusH M. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant, 2001, 27(3): 235-235

[5]

YooJ U, BarthelT S, NishimuraK, et al. . The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg (AM), 1998, 80(12): 1745-1745

[6]

LiechtyK W, MacKenzieT C, ShaabanA F, et al. . Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med, 2000, 6(11): 1282-1282

[7]

WorsterA A, Brower-TolandB D, FortierL A, et al. . Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-betal in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res, 2001, 19(4): 738-738

[8]

ManiatopulosC, SoddekJ, MelcherA H. Bone formationin vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res, 1998, 254317-317

[9]

WorsterA A, Brower TolandB D, FortierH M, et al. . Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations. J Ortho Res, 2000, 1868-68

[10]

OlmezU, RyanL M, KurupI V, et al. . Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta-stimulated chondrocytes and cartilage. Osteoarthritis Cartilage, 1994, 2(3): 149-149

AI Summary AI Mindmap
PDF

93

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/